Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 3, 2002, Pages 318-323

  Utzinger, Jürg ^a,b   Chollet, Jacques ^a   Tu, Zuwu ^a,c   Shuhua, Xiao ^d   Tanner, Marcel ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b PRINCETON UNIVERSITY   (United States)

^c Hubei Institute of Schistosomiasis Control   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Animal models; Artemether; Artesunate; Chemotherapy; Experimental infections; Malaria monotherapy treatment regimen; Mice; Schistosoma mansoni; Schistosomiasis

Indexed keywords

ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOSE RESPONSE; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; MALARIA; MALE; MONOTHERAPY; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALIA; NEMATODA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0036064218     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90110-0     Document Type: Article

References (46)

1. Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice
2. A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action
3. Praziquantel-quality, dosages and markers of resistance
4. Therapeutic evaluation of artesunate in experimental Schistosoma mansoni infection
5. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: A double-blind, randomized, placebo-controlled study
6. The global status of schistosomiasis and its control
7. Chemotherapy of schistosomiasis: An update
8. Praziquantel: Is there real resistance and are there alternatives?
9. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
10. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria
11. Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal
12. What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections?
13. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected school-children
14. Drug-resistant schistosomiasis: Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific
15. Drug resistance in human helminths: Current situation and lessons from livestock
16. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence
17. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel
18. Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers
19. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats
20. Studies on prophylactic effect of artesunate on schistosomiasis japonica
21. Biliary metabolites of beta-artemether in rats: Biotransformations of an antimalarial endoperoxide
22. Artemisinin derivatives for treating severe malaria (Cochrane Review)
23. Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria
24. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
25. Schistosoma mansoni: Chemotherapy of infections of different ages
26. Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial
27. The potential of artemether for the control of schistosomiasis
28. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals
29. Grapefruit juice increases the bioavailability of artemether
30. Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials
31. Antimalarial drug resistance and combination chemotherapy
32. The Control of Schistosomiasis: Second Report of the WHO Expert Committee
33. The use of artemisinin and its derivatives as antimalarial drugs
34. Report of the WHO Informal Consultation on Schistosomiasis Control
35. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis: First Report of the Joint WHO Expert Committees
36. Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel
37. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni
38. Effect of arteether on Schistosoma japonicum
39. Experimental studies on early treatment of schistosomal infection with artemether
40. Preventive effect of artemether in rabbits infected with Schistosoma japonicum cercariae
41. The prophylactic effects of artemether against Schistosoma japonicum infections
42. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni
43. Effect of artemether against Schistosoma haematobium in experimentally infected hamsters
44. Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits
45. The 1992-1999 World Bank schistosomiasis research initiative in China: Outcome and perspectives
46. Artemisinin: An endoperoxidic antimalarial from Artemisia annua L